Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises in the divestment of Nordic Water
Mandate

Vinge advises in the divestment of Nordic Water

January 12, 2021 Employment and Benefits Banking and Finance M&A

Vinge advises Alder and the other shareholders in connection with the divestment of Nordic Water Holding AB and its subsidiaries to Sulzer AG. Since 1961, the Nordic Water Group is active within development, distribution and service of solutions and products for wastewater treatment.

The Group has its headquarters in Gothenburg and has approximately 200 employees in six countries. Sulzer AG is a Swiss industrial engineering and manufacturing company. The transaction is subject to customary conditions and approvals and is expected to close in Q1 2021.

Vinge’s team consisted of, among others, Johan Larsson, Carl Sander, Hannah Kajlinger and Olivia Belding (M&A), Viktoria Owetz Leyva (VDR Specialist), Albert Wållgren and Ludvig Wettergren (Financial Arrangements), as well as Ebba Svenburg and Gustav Lindgren (Employment).

 

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025